June 24, 2024
Research to understand and quantify the effectiveness of a specific combination therapy against breast cancer has been singled out to receive the Purdue Women’s Global Health Institute’s 2024 Catherine Peachey Breast Cancer Research Program Award.
Promising breast cancer research receives WGHI’s Catherine Peachey grant
June 21, 2024
The American College of Veterinary Internal Medicine (ACVIM) recently announced recipients of the esteemed 2024 ACVIM Recognition Awards, and one of them is Dr. François-René Bertin, Purdue associate professor of large animal internal medicine. Dr. Bertin, who joined the Purdue Veterinary Medicine faculty in January of this year, received the William R. Fenner Early Career Award for Outstanding Service. The award recognizes ACVIM Diplomates who exemplify exceptional service in a volunteer capacity in the ACVIM and/or their specialty within the first 10 years following board-certification.
Purdue Associate Professor of Large Animal Internal Medicine Receives Prestigious ACVIM Award
June 21, 2024
The number of women in STEM fields, including engineering, has increased in recent decades, paving the way for a brighter, more representative future in the U.S. International Women in Engineering Day spotlights these trailblazing women and their achievements in various engineering disciplines. Founded by the Women’s Engineering Society in the U.K., the day is now recognized across the world on June 23. The day has the broader aim of inspiring future generations of women engineers, fostering diversity and inclusivity in the field.
International Women in Engineering Day: Q&A with Kari Clase and Upinder Kaur
June 20, 2024
Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). AML is a cancer that begins in bone marrow and sometimes metastasizes to the central nervous system, liver, lymph nodes, spleen and testicles.
June 20, 2024
Indiana University School of Medicine researchers and their collaborators have uncovered molecular insights expected to enhance treatment options for acute myeloid leukemia (AML), a rare and severe blood and bone marrow cancer. With a new chemical compound engineered to overcome drug-resistant gene mutations not targeted by current treatments, the researchers aim to provide a new alternative with longer-lasting effects and improve outcomes for future patients battling this aggressive disease.
Acute myeloid leukemia discovery tackles drug-resistant gene mutations
June 20, 2024
Researchers at Purdue University’s College of Science have developed a patent-pending compound called HSN748 to treat drug-resistant acute myeloid leukemia (AML). AML is a cancer that begins in bone marrow and sometimes metastasizes to the central nervous system, liver, lymph nodes, spleen and testicles.
‘Like a hand fitting into a glove’: Purdue-engineered compound designed to treat drug-resistant ...
June 20, 2024
Purdue University researchers are introducing a new biosensor technology to the agricultural industry inspired by advancements achieved during the COVID-19 pandemic.
Paper-based biosensor offers fast, easy detection of fecal contamination on produce farms
June 19, 2024
Purdue University researchers are introducing a new biosensor technology to the agricultural industry inspired by advancements achieved during the COVID-19 pandemic.
Paper-based biosensor offers fast, easy detection of fecal contamination on produce farms
June 17, 2024
Turning knowledge into impact, Purdue University researchers rank 4th among U.S. universities — 5th in the world — in U.S. patents received in 2023, with 201 patents.
June 11, 2024
The Venture Club of Indiana on Tuesday announced the winners of its annual Innovation Showcase. Twenty startups presented their ideas before a panel of judges, with winners being announced in three categories: Digital Tech, Life Sciences and Ag Tech/Hard Tech.
